BACKGROUND: Arteriovenous malformation (AVM) patients present in 4 ways relative to hemorrhage: (1) unruptured, without a history or radiographic evidence of old hemorrhage (EOOH); (2) silent hemorrhage, without a bleeding history but with EOOH; (3) ruptured, with acute bleeding but without EOOH; and (4) reruptured, with acute bleeding and EOOH. OBJECTIVE: We hypothesized that characteristics and outcomes in the unrecognized group of silent hemorrhage patients may differ from those of unruptured patients. METHODS: Two hundred forty-two patients operated-on since 1997 were categorized by hemorrhage status and hemosiderin positivity in this cohort study: unruptured (group 1), silent hemorrhage (group 2), and ruptured/reruptured (group 3/4). Group 3/4 was combined because hemosiderin cannot distinguish acute hemorrhage from older silent hemorrhage. RESULTS: Hemosiderin was found in 45% of specimens. Seventy-five patients (31.0%) had unruptured AVMs, 30 (12.4%) had silent hemorrhage, and 137 (56.6%) had ruptured/reruptured AVMs. Deep drainage, posterior fossa location, preoperative modified Rankin Scale (mRS) score, outcome, and macrophage score were different across groups. Only the macrophage score was different between the groups without clinical hemorrhage. Outcomes were better in silent hemorrhage patients than in those with frank rupture (mean mRS scores of 1.2 and 1.7, respectively). CONCLUSION: One-third of patients present with silent AVM hemorrhage. No clinical or anatomic features differentiate these patients from unruptured patients, except the presence of hemosiderin and macrophages. Silent hemorrhage can be diagnosed using magnetic resonance imaging with iron-sensitive imaging. Silent hemorrhage portends an aggressive natural history, and surgery halts progression to rerupture. Good final mRS outcomes and better outcomes than in those with frank rupture support surgery for silent hemorrhage patients, despite the findings of ARUBA.
BACKGROUND:Arteriovenous malformation (AVM) patients present in 4 ways relative to hemorrhage: (1) unruptured, without a history or radiographic evidence of old hemorrhage (EOOH); (2) silent hemorrhage, without a bleeding history but with EOOH; (3) ruptured, with acute bleeding but without EOOH; and (4) reruptured, with acute bleeding and EOOH. OBJECTIVE: We hypothesized that characteristics and outcomes in the unrecognized group of silent hemorrhagepatients may differ from those of unruptured patients. METHODS: Two hundred forty-two patients operated-on since 1997 were categorized by hemorrhage status and hemosiderin positivity in this cohort study: unruptured (group 1), silent hemorrhage (group 2), and ruptured/reruptured (group 3/4). Group 3/4 was combined because hemosiderin cannot distinguish acute hemorrhage from older silent hemorrhage. RESULTS: Hemosiderin was found in 45% of specimens. Seventy-five patients (31.0%) had unruptured AVMs, 30 (12.4%) had silent hemorrhage, and 137 (56.6%) had ruptured/reruptured AVMs. Deep drainage, posterior fossa location, preoperative modified Rankin Scale (mRS) score, outcome, and macrophage score were different across groups. Only the macrophage score was different between the groups without clinical hemorrhage. Outcomes were better in silent hemorrhagepatients than in those with frank rupture (mean mRS scores of 1.2 and 1.7, respectively). CONCLUSION: One-third of patients present with silent AVM hemorrhage. No clinical or anatomic features differentiate these patients from unruptured patients, except the presence of hemosiderin and macrophages. Silent hemorrhage can be diagnosed using magnetic resonance imaging with iron-sensitive imaging. Silent hemorrhage portends an aggressive natural history, and surgery halts progression to rerupture. Good final mRS outcomes and better outcomes than in those with frank rupture support surgery for silent hemorrhagepatients, despite the findings of ARUBA.
Authors: Yi Guo; Tara Saunders; Hua Su; Helen Kim; Deniz Akkoc; David A Saloner; Steven W Hetts; Christopher Hess; Michael T Lawton; Andrew W Bollen; Tony Pourmohamad; Charles E McCulloch; Tarik Tihan; William L Young Journal: Stroke Date: 2012-02-02 Impact factor: 7.914
Authors: Sang-Beom Jeon; Gunjan Parikh; H Alex Choi; Neeraj Badjatia; Kiwon Lee; J Michael Schmidt; Hector Lantigua; E Sander Connolly; Stephan A Mayer; Jan Claassen Journal: Neurosurgery Date: 2014-02 Impact factor: 4.654
Authors: M M A Conijn; M I Geerlings; G-J Biessels; T Takahara; T D Witkamp; J J M Zwanenburg; P R Luijten; J Hendrikse Journal: AJNR Am J Neuroradiol Date: 2011-05-05 Impact factor: 3.825
Authors: Rustam Al-Shahi Salman; Philip M White; Carl E Counsell; Johann du Plessis; Janneke van Beijnum; Colin B Josephson; Tim Wilkinson; Catherine J Wedderburn; Zoe Chandy; E Jerome St George; Robin J Sellar; Charles P Warlow Journal: JAMA Date: 2014 Apr 23-30 Impact factor: 56.272
Authors: David M Hasan; Matthew Amans; Tarik Tihan; Christopher Hess; Yi Guo; Soonmee Cha; Hua Su; Alastair J Martin; Michael T Lawton; Edward A Neuwelt; David A Saloner; William L Young Journal: Transl Stroke Res Date: 2012-07 Impact factor: 6.829
Authors: Paul A Yates; Victor L Villemagne; Kathryn A Ellis; Patricia M Desmond; Colin L Masters; Christopher C Rowe Journal: Front Neurol Date: 2014-01-06 Impact factor: 4.003
Authors: J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz Journal: Lancet Date: 2013-11-20 Impact factor: 79.321
Authors: Chun-Xue Wu; Li Ma; Xu-Zhu Chen; Xiao-Lin Chen; Yu Chen; Yuan-Li Zhao; Christopher Hess; Helen Kim; Heng-Wei Jin; Jun Ma Journal: World Neurosurg Date: 2018-05-30 Impact factor: 2.104
Authors: Ethan A Winkler; Harjus Birk; Jan-Karl Burkhardt; Xiaolin Chen; John K Yue; Diana Guo; W Caleb Rutledge; George F Lasker; Carlene Partow; Tarik Tihan; Edward F Chang; Hua Su; Helen Kim; Brian P Walcott; Michael T Lawton Journal: J Neurosurg Date: 2018-12-01 Impact factor: 5.115
Authors: Xiaolin Chen; Daniel L Cooke; David Saloner; Jeffrey Nelson; Hua Su; Michael T Lawton; Christopher Hess; Tarik Tihan; Yuanli Zhao; Helen Kim Journal: Stroke Date: 2017-08-30 Impact factor: 7.914
Authors: Ali Tayebi Meybodi; Helen Kim; Jeffrey Nelson; Steven W Hetts; Timo Krings; Karel G terBrugge; Marie E Faughnan; Michael T Lawton Journal: Neurosurgery Date: 2018-01-01 Impact factor: 4.654